$25.61 Million in Sales Expected for Flexion Therapeutics, Inc. (NASDAQ:FLXN) This Quarter

Retrieved on: 2021-01-06 09:44:30

Tags for this article:

Click the tags to see associated articles and topics

$25.61 Million in Sales Expected for Flexion Therapeutics, Inc. (NASDAQ:FLXN) This Quarter. View article details on hiswai:

Excerpt

Vanguard Group Inc. now owns 2,274,797 shares of the specialty pharmaceutical company's stock valued at $29,913,000 after buying an additional ...

Article found on: www.marketbeat.com